CrossrefInfokarte
Neoadjuvant Nivolumab–Ipilimumab versus Platinum-Based Chemotherapy in Muscle-Invasive Bladder Cancer: A Single-Institution, Propensity-Weighted Cohort Study
Cancer Management and Research · 2026-11 · Volume 18 · 1-13
DOI: 10.2147/cmar.s642002 ↗Abstract
Kein Abstract verfügbar.
EUVIMED